Neurogene Inc.
NEW YORK, NY · Founded 2018 · CIK 0001768250 · Biotech · Public
Gene therapies for rare neurological diseases
neurogene.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $106M
- 2 Form D · Dec 2020
- 69 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 5
- 0 granted · 5 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2018201920202021
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $37,500,001 | |
| Private capital raised | Form D · SEC | $68,999,980 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2819 | STEL Technologies, LLC | — | — |
| 2820 | Passage Bio | — | $110M |
| 2821 | Acadia Pharmaceuticals | — | $107M |
| 2822 | Neurogene Inc. | — | $106M |
| 2823 | Ovid Therapeutics | — | $106M |
| 2824 | LEAP THERAPEUTICS, INC. | — | $105M |
| 2825 | CENTRILLION BIOSCIENCES, INC. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Robert BaffiDirector
- Stephen BiggarDirector
- Christine CvijicExecutive Officer
- Cory FreedlandDirector
- Rachel McMinnDirector · Executive Officer
- Srdjan StankovicDirector
- Caroline StoutDirector
Patents
- NEO-2/15 Variants and Uses Thereof for Preferentially Stimulating T-Regulatory Cellsapplication
- Polypeptides And Uses Thereof For Preferentially Stimulating T-regulatory Cellsapplication
- Recombinant Optimized Galc Constructs And Methods For Treating Galc-associated Disordersapplication
- INTERLEUKIN-2 Receptor Beta (IL-2RB) Binding Polypeptidesapplication
- Recombinant Optimized GALC Constructs and Methods for Treating GALC-Associated Disordersapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.